Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection

被引:38
|
作者
Zheng, Hongmei [1 ]
Zhan, Yuting [1 ]
Zhang, Yuting [1 ]
Lin, Sile [1 ]
Lu, Junmi [1 ]
Yang, Yang [1 ]
Wen, Qiuyuan [1 ]
Fan, Songqing [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China
来源
CANCER MEDICINE | 2019年 / 8卷 / 16期
基金
中国国家自然科学基金;
关键词
biomarker; G3BP1; nonsmall cell lung cancer; p-AKT; prognosis; YB1; EPITHELIAL-MESENCHYMAL TRANSITION; GTPASE-ACTIVATING PROTEIN; POTENTIAL TARGETS; BINDING PROTEIN-1; SIGNALING PATHWAY; BREAST-CANCER; YB-1; PROMOTES; CARCINOMA; OVEREXPRESSION;
D O I
10.1002/cam4.2579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose G3BP1 is an RNA-binding protein and plays roles in regulating signaling pathway. YB-1 is a DNA/RNA binding protein encoded by YBX1 gene. Phosphorylated AKT (p-AKT) acts as a pivotal molecule in PI3K/AKT pathway. YB-1 drives stress granules (SGs) formation by activating G3BP1 translation under diverse conditions. SGs are involved in many different metabolic and signaling pathways which may include PI3K/AKT/mTOR. So far, there has been no report on the relationship between expression of G3BP1, p-AKT, and YB1 and clinicopathological features/prognosis in surgically resected nonsmall cell lung cancer (NSCLC) patients. Methods In this study, data from TCGA (The Cancer Genome Atlas) were downloaded to investigate the mRNA expression of G3BP1 and YB1 (YBX1) and their correlation in NSCLC. Also, expression of G3BP1, YB1, and p-AKT proteins was studied using immunohistochemistry in tissue microarrays of NSCLC and in noncancerous lung tissues. Results We found that the mRNA expression of G3BP1 and YB1 was higher in NSCLC tissues (both P .05), and G3BP1 was positively correlated with YB1 in mRNA level (r = .399, P < .001). Also, expression of G3BP1, YB1, and p-AKT proteins was higher in NSCLC tissues (all P < .05). And higher expression of G3BP1 and YB1 proteins was seen in patients with clinical stage II and III compared with stage I (both P < .05). Besides, expression of G3BP1 protein had a positive correlation with YB1 and p-AKT (both P < .05). Moreover, overall survival was shorter in patients with overexpression of G3BP1, YB1, and p-AKT proteins (all P < .05). Multivariate analysis confirmed that overexpression of G3BP1 protein was an independent poorer prognostic factor for NSCLC patients (P = .039). Conclusion G3BP1 may play a crucial role in activating PI3K/AKT/mTOR pathway. G3BP1 might be served as a novel prognostic biomarker for surgically resected NSCLC patients, which afforded new insights into the study on the mechanism and therapy of NSCLC.
引用
收藏
页码:6894 / 6903
页数:10
相关论文
共 26 条
  • [1] Elevated HSP90 associates with expression of HIF-1α and p-AKT and is predictive of poor prognosis in nasopharyngeal carcinoma
    Feng, Juan
    Xie, Guiyuan
    Zhan, Yuting
    Lu, Junmi
    Xu, Lina
    Fan, Songqing
    Wang, Weiyuan
    HISTOPATHOLOGY, 2019, 75 (02) : 202 - 212
  • [2] Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection
    Tang, Yaoxiang
    Luo, Jiadi
    Yang, Yang
    Liu, Sile
    Zheng, Hongmei
    Zhan, Yuting
    Fan, Songqing
    Wen, Qiuyuan
    PLOS ONE, 2022, 17 (06):
  • [3] Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
    Wen, Qiuyuan
    Zhan, Yuting
    Zheng, Hongmei
    Zang, Hongjing
    Luo, Jiadi
    Zhang, Yuting
    Wang, Weiyuan
    Feng, Juan
    Lu, Junmi
    Chen, Lingjiao
    Fan, Songqing
    DIAGNOSTIC PATHOLOGY, 2019, 14 (01)
  • [4] Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
    Qiuyuan Wen
    Yuting Zhan
    Hongmei Zheng
    Hongjing Zang
    Jiadi Luo
    Yuting Zhang
    Weiyuan Wang
    Juan Feng
    Junmi Lu
    Lingjiao Chen
    Songqing Fan
    Diagnostic Pathology, 14
  • [5] Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection
    Li, Dandan
    Meng, Qingwei
    Zhang, Huijuan
    Feng, Ting
    Liu, Meiyan
    Cai, Li
    TUMOR BIOLOGY, 2016, 37 (04) : 4393 - 4398
  • [6] Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer
    Yang, Fang
    Gao, Yina
    Geng, Jingshu
    Qu, Di
    Han, Qiuyue
    Qi, Jiping
    Chen, Gongyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (12): : 2846 - 2854
  • [7] Downregulation of HDPR1 Is Associated With Poor Prognosis and Affects Expression Levels of p120-Catenin and β-Catenin in Nonsmall Cell Lung Cancer
    Yang, Zhi-Qiang
    Zhao, Yue
    Liu, Yang
    Zhang, Jun-Yi
    Zhang, Sheng
    Jiang, Gui-Yang
    Zhang, Peng-Xin
    Yang, Lan-He
    Liu, Di
    Li, Qing-Chang
    Wang, En-Hua
    MOLECULAR CARCINOGENESIS, 2010, 49 (05) : 508 - 519
  • [8] Co-expression of PD-L1 and HIF-1α predicts poor prognosis in Patients with Non-small Cell Lung Cancer after surgery
    Zheng, Hongmei
    Ning, Yue
    Zhan, Yuting
    Liu, Sile
    Yang, Yang
    Wen, Qiuyuan
    Fan, Songqing
    JOURNAL OF CANCER, 2021, 12 (07): : 2065 - 2072
  • [9] Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer
    Zhao, Weiqiang
    Huang, Cheng C.
    Otterson, Gregory A.
    Leon, Marino E.
    Tang, Yan
    Shilo, Konstantin
    Villalona, Miguel A.
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [10] Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma
    Cui, Yan
    Cui, Chun-ai
    Yang, Zhao-ting
    Ni, Wei-dong
    Jin, Yu
    Xuan, Yan-hua
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 102 (02) : 347 - 353